OrbiMed’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,680,580
| Closed | -$1.33M | – | 101 |
|
|
2025
Q1 | $1.33M | Hold |
1,680,580
| – | – | 0.03% | 94 |
|
|
2024
Q4 | $2.77M | Hold |
1,680,580
| – | – | 0.06% | 92 |
|
|
2024
Q3 | $5.88M | Buy |
1,680,580
+325,228
| +24% | +$1.14M | 0.11% | 91 |
|
|
2024
Q2 | $4.45M | Hold |
1,355,352
| – | – | 0.09% | 91 |
|
|
2024
Q1 | $9.95M | Buy |
1,355,352
+827,272
| +157% | +$6.07M | 0.18% | 80 |
|
|
2023
Q4 | $1.98M | Buy |
+528,080
| New | +$1.98M | 0.04% | 96 |
|
|
2016
Q2 | – | Sell |
-692,900
| Closed | -$1.25M | – | 138 |
|
|
2016
Q1 | $1.25M | Hold |
692,900
| – | – | 0.01% | 131 |
|
|
2015
Q4 | $2.34M | Hold |
692,900
| – | – | 0.02% | 117 |
|
|
2015
Q3 | $3.69M | Hold |
692,900
| – | – | 0.04% | 114 |
|
|
2015
Q2 | $4.48M | Hold |
692,900
| – | – | 0.04% | 115 |
|
|
2015
Q1 | $3.39M | Hold |
692,900
| – | – | 0.03% | 113 |
|
|
2014
Q4 | $3.49M | Hold |
692,900
| – | – | 0.03% | 107 |
|
|
2014
Q3 | $3.53M | Hold |
692,900
| – | – | 0.04% | 107 |
|
|
2014
Q2 | $4.37M | Hold |
692,900
| – | – | 0.05% | 103 |
|
|
2014
Q1 | $6.75M | Sell |
692,900
-9,100
| -1% | -$88.6K | 0.08% | 93 |
|
|
2013
Q4 | $4.41M | Buy |
+702,000
| New | +$4.41M | 0.06% | 93 |
|